Evidence map›Paper›PMID 25396429›Full record

ArticlePloS one2014

Ligand binding reveals a role for heme in translationally-controlled tumor protein dimerization.

Andrew T Lucas, Xiangping Fu, JingJing Liu, Mary K Brannon, Jianhua Yang, Daniel G S Capelluto, Carla V Finkielstein

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Andrew T LucasIntegrated Cellular Responses Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America; Protein Signaling Domains Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America.
Xiangping FuIntegrated Cellular Responses Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America.
JingJing LiuIntegrated Cellular Responses Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America.
Mary K BrannonProtein Signaling Domains Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America.
Jianhua YangIntegrated Cellular Responses Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America.
Daniel G S CapellutoProtein Signaling Domains Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America.
Carla V FinkielsteinIntegrated Cellular Responses Laboratory, Virginia Bioinformatics Institute, Department of Biological Sciences, Virginia Tech, Blacksburg, Virginia, United States of America.
Virginia Tech · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The translationally-controlled tumor protein (TCTP) is a highly conserved, ubiquitously expressed, abundant protein that is broadly distributed among eukaryotes. Its biological function spans numerous cellular processes ranging from regulation of the cell cycle and microtubule stabilization to cell growth, transformation, and death processes. In this work, we propose a new function for TCTP as a "buffer protein" controlling cellular homeostasis. We demonstrate that binding of hemin to TCTP is mediated by a conserved His-containing motif (His76His77) followed by dimerization, an event that involves ligand-mediated conformational changes and that is necessary to trigger TCTP's cytokine-like activity. Mutation in both His residues to Ala prevents hemin from binding and abrogates oligomerization, suggesting that the ligand site localizes at the interface of the oligomer. Unlike heme, binding of Ca2+ ligand to TCTP does not alter its monomeric state; although, Ca2+ is able to destabilize an existing TCTP dimer created by hemin addition. In agreement with TCTP's proposed buffer function, ligand binding occurs at high concentration, allowing the "buffer" condition to be dissociated from TCTP's role as a component of signal transduction mechanisms.

Indexed as

Amino Acid MotifsAmino Acid SequenceBiomarkers, TumorCalciumChromatography, High Pressure LiquidCircular DichroismComputational BiologyCross-Linking ReagentsDimerizationElectrophoresis, Polyacrylamide GelFluorescenceHeminHomeostasisHumansMolecular Sequence DataNuclear Magnetic Resonance, BiomolecularBiomarkers, TumorCalciumCross-Linking ReagentsHeminTPT1 protein, humanTumor Protein, Translationally-Controlled 1

Identifiers

PMID25396429
PMCPMC4232476
OpenAlexW2029160410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.